Cleared Traditional

K010700 - RANDOX MYOGLOBIN (FDA 510(k) Clearance)

May 2001
Decision
61d
Days
Class 2
Risk

K010700 is an FDA 510(k) clearance for the RANDOX MYOGLOBIN. This device is classified as a Myoglobin, Antigen, Antiserum, Control (Class II - Special Controls, product code DDR).

Submitted by Randox Laboratories, Ltd. (Crumlin, Co. Antrim, IE). The FDA issued a Cleared decision on May 8, 2001, 61 days after receiving the submission on March 8, 2001.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5680.

Submission Details

510(k) Number K010700 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2001
Decision Date May 08, 2001
Days to Decision 61 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code DDR — Myoglobin, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5680